Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Jan 19, 2024 7:12pm
348 Views
Post# 35836841

Auditor Change posted on sedar yesterday

Auditor Change posted on sedar yesterdayTHERALASE TECHNOLOGIES INC.
 
CHANGE OF AUDITOR NOTICE
 
TO: RICHTER LLP (the “Predecessor Auditor”)
 
AND TO: AGT PARTNERS LLP (the “Successor Auditor”)
 
DATED: January 12, 2024
 
NOTICE IS HEREBY GIVEN that, on the advice of the Audit Commitee of Theralase Technologies Inc. (the “Corporation”), the Board of Directors of the Corporation resolved as of January 12, 2024, that: (i) the resignation of the Predecessor Auditor, with effect from January 12, 2024, as auditor of the Corporation be accepted, and (b) the Successor Auditor be appointed as auditor of the Corporation effective as of January 12, 2024, to hold office until the next annual meeting of the shareholders of the Corporation at a remuneration to be fixed by the Board of Directors of the Corporation. In accordance with National Instrument 51-102 – Continuous Disclosure Obligations of the Canadian Securities Administrators (“NI 51-102”), please be advised as follows:
 
(a) the Predecessor Auditor resigned as auditor of the Corporation at the request of the Board of Directors of the Corporation;

(b) the Predecessor Auditor has not expressed a modified opinion in its reports for the two most recently completed fiscal years of the Corporation, nor for the period from the most recently completed period for which the Predecessor Auditor issued an audit report in respect of the Corporation and the date of this Notice;

(c) the resignation of the Predecessor Auditor, and the appointment of the Successor Auditor, as auditor of the Corporation were considered by the Audit Commitee and approved by the Board of Directors of the Corporation; and

(d) in the opinion of the Board of Directors of the Corporation, no “reportable event” (as defined in NI 51-102) has occurred in connection with the audits of the two most recently completed fiscal years of the Corporation, nor any period from the most recently completed period for which the Predecessor Auditor issued an audit report in respect of the Corporation and the date of this Notice.
 
THERALASE TECHNOLOGIES INC.
 
 
Kristina Hachey
Chief Financial Officer

<< Previous
Bullboard Posts
Next >>